cwbe coordinatez:
101
63539
4879893
7180263
7180296

ABSOLUT
KYBERIA
permissions
you: r,
system: public
net: yes

neurons

stats|by_visit|by_K
source
tiamat
K|my_K|given_K
last
commanders
polls

total descendants::1
total children::1
show[ 2 | 3] flat
PR push bol belmi dobre koordinovany, nepochybne.
ale aj tak, konspiracia aby preventivne testovanie BRCA1 (alebo akejkolvek inej predispozicie) bolo platene z americkych dani? pls, dajte mi viac takychto konspiracii :)
suvislost so sudnym sporom.. no je to na sude, tam asi vela PR uz netreba.




000001010006353904879893071802630718029607180311
evad
 evad      18.05.2013 - 12:02:54 , level: 1, UP   NEW
myslim tuto cast

Details on the upcoming Supreme Court decision
The ACLU and the Public Patent Foundation filed a lawsuit in 2009, challenging the corporate ownership of human genes. Anyone who believes in women's rights, human rights, civil rights or even the right to eat non-GMO foods should immediately agree that corporations should NOT be able to patent human genes and then use those patents to rake in billions of dollars in profits while stifling scientific research into those genes.

A question to all women reading this: Do you believe a corporation in Utah owns your body? If not, you should be opposed to corporate ownership of human genes. It also means you should oppose Angelina Jolie's P.R. campaign because although she's running a brilliant public relations campaign, behind the scenes her actions are feeding potentially trillions of dollars of profits directly into the for-profit human gene patenting industry that denies human beings ownership over their own genetic code.

The ACLU explains the basics of its lawsuit against Myriad Genetics as follows:

On May 12, 2009, the ACLU and the Public Patent Foundation (PUBPAT) filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer, BRCA1 and BRCA2, are unconstitutional and invalid. On November 30, 2012, the Supreme Court agreed to hear argument on the patentability of human genes. The ACLU argued the case before the U.S. Supreme Court on April 15, 2013. We expect a decision this summer.

On behalf of researchers, genetic counselors, women patients, cancer survivors, breast cancer and women's health groups, and scientific associations representing 150,000 geneticists, pathologists, and laboratory professionals, we have argued that human genes cannot be patented because they are classic products of nature. The suit charges that the gene patents violate the First Amendment and stifle diagnostic testing and research that could lead to cures and that they limit women's options regarding their medical care.

Got that? If the Supreme Court rules against Myriad Genetics, it will cause a multi-billion-dollar breast cancer genetic testing industry to collapse virtually overnight. This means a huge loss for not just Myriad, but also many other human gene corporations that wish to exploit the human body -- including the bodies of women -- for monopolistic profits. (All patents are government-granted monopolies.) Ultimately, trillions of dollars in corporate gene patents are at stake here.